Sean Rudd, Assistant professor in Thomas Helleday’s research group (SciLifeLab/Karolinska Institutet), has been awarded the Junior Investigator Award from the Swedish Cancer Society – Cancerfonden.
The Swedish Cancer Society funds research positions with the purpose of getting a continuity in cancer research, thereby increasing the possibility of identifying and treating cancer.
Sean Rudd will be receiving funding for six years for his research that focuses on gaining a better understanding of the chemotherapies currently available in cancer treatment. In particular, his team is studying the metabolic processes within cancer cells, such as those responsible for maintaining genome stability, and how these can be exploited to enhance the efficacy of existing therapies.
In total, 14 research positions are awarded, on top of the current 62 researchers that are already receiving funding. Other grants are positions such as Senior Investigator Award and Senior Clinical Investigator Award. Specific to this year is also two fellowships for research on ovarian cancer.